Seeking Alpha

An FDA panel has voted 3-14 that Abbott (ABT) has not found right dose for its irritable bowel...

An FDA panel has voted 3-14 that Abbott (ABT) has not found right dose for its irritable bowel syndrome drug Humira. Last week, FDA staff had questioned whether Humira had a real benefit for people with the disease who had already tried other treatments.
Comments (2)
  • share up 0.11 !!!!!!!!!!
    28 Aug 2012, 02:25 PM Reply Like
  • IBS or irritable bowel syndrome is a completely different condition from IBD or Inflammatory Bowel Disease. IBD consists of Crohn's Disease as well as Ulcerative Colitis, for which Humira was attempting to obtain another indication.
    28 Aug 2012, 03:06 PM Reply Like
DJIA (DIA) S&P 500 (SPY)